201 related articles for article (PubMed ID: 4399793)
1. [Allergic rhinitis treated with Tavegyl].
Ronning-Arnesen A
Tidsskr Nor Laegeforen; 1971 Nov; 91(32):2329-31. PubMed ID: 4399793
[No Abstract] [Full Text] [Related]
2. [Experience in the clinical use of Tavegyl in nose diseases--judgment of effectiveness by cross-over method].
Sugiura S
Jibiinkoka; 1971 Nov; 43(11):931-42. PubMed ID: 4401875
[No Abstract] [Full Text] [Related]
3. Allergic rhinitis and its control by antihistamines: clinical trial of Tavegyl (meclastine).
Roncevich A
Curr Ther Res Clin Exp; 1969 Oct; 11(10):625-33. PubMed ID: 4390563
[No Abstract] [Full Text] [Related]
4. [Clinical experience with Tavegyl in allergic rhinitis].
Frostad AB
Tidsskr Nor Laegeforen; 1972 Mar; 92(7):506-7. PubMed ID: 4402499
[No Abstract] [Full Text] [Related]
5. [Tavegyl in the treatment of allergic diseases and neurovascular disorders of the nose].
Melik A
Schweiz Rundsch Med Prax; 1970 May; 59(18):676-8. PubMed ID: 4396440
[No Abstract] [Full Text] [Related]
6. [Clinical experience with HS-592 (a new antihistaminic) for so-called allergic rhinitis].
Baba S; Oashi M; Seno Y; Maruo T
Penn Dent J (Phila); 1970 Mar; 73(2):319-22. PubMed ID: 4192065
[No Abstract] [Full Text] [Related]
7. [Clinical trial of a new antihistaminic for allergic rhinitis].
Axelsson A
Lakartidningen; 1970 Jul; 67(27):3105-8. PubMed ID: 4393901
[No Abstract] [Full Text] [Related]
8. [Determination of therapeutic effect of antihistaminics---clinical effect of HS 592].
Okuda M; Sekine K
Jibiinkoka; 1970 Jul; 42(7):555-7. PubMed ID: 4394032
[No Abstract] [Full Text] [Related]
9. Meclastine in hay fever.
Practitioner; 1972 Jun; 208(248):839-42. PubMed ID: 4402970
[No Abstract] [Full Text] [Related]
10. [Experience with a new antihistaminic in dermatology. Results of a clinical double blind trial].
Eberhartinger C; Ebner H
Wien Med Wochenschr; 1969 Sep; 119(38):630-2. PubMed ID: 4390510
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of antihistamine, HS-592, in seasonal and perennial allergic rhinitis.
Pan A
Ann Allergy; 1970 Feb; 28(2):69-72. PubMed ID: 4403482
[No Abstract] [Full Text] [Related]
12. Clinical trials of a new antihistaminic HS 592.
Safwat FM
Rev Laryngol Otol Rhinol (Bord); 1972; 93(11):743-6. PubMed ID: 4146016
[No Abstract] [Full Text] [Related]
13. [Clinical study of a new antihistaminic agent, Tavist].
Gyde MC
Vie Med Can Fr; 1972 Feb; 1(2):151-5. PubMed ID: 4404676
[No Abstract] [Full Text] [Related]
14. [Experimental and clinical studies of a new histamine antagonist].
Kallós P
Lakartidningen; 1969 Jun; 66():Suppl II:57+. PubMed ID: 4392857
[No Abstract] [Full Text] [Related]
15. [Efficacy and tolerability of new antiallergic drugs in acute pollinosis].
Wüthrich B; Dieterich HA
Schweiz Rundsch Med Prax; 1982 Sep; 71(36):1367-72. PubMed ID: 6127672
[No Abstract] [Full Text] [Related]
16. [Evaluation of the clinical usefulness of the antihistamine preparation HS-592 (Tavegyl-Sandoz) in treatment of allergic rhinitis and sinusitis].
Semczuk B; Klonowski S
Pol Tyg Lek; 1970 Feb; 25(8):303-5. PubMed ID: 4392044
[No Abstract] [Full Text] [Related]
17. Patient evaluation of clemastine fumarate and comparison with other antihistamines.
Kriz RJ
Wis Med J; 1981 Dec; 80(12):31-3. PubMed ID: 6119852
[No Abstract] [Full Text] [Related]
18. "Tavegyl" (meclastine): a pilot trial in allergic rhinitis.
Grove B
Med J Aust; 1969 Jun; 1(24):1234-6. PubMed ID: 4389674
[No Abstract] [Full Text] [Related]
19. [9,9-dioxopromethazine (Prothanon) at the trial in hay fever].
Busse G; Fritsche F
Pharmazie; 1970 Feb; 25(2):106-8. PubMed ID: 4393057
[No Abstract] [Full Text] [Related]
20. [Clinical evaluation of a new antihistaminic: HS-592].
von Bernath Z
Prensa Med Argent; 1971 Jul; 58(21):1071-5. PubMed ID: 4398545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
